New insights on HS phenotypes and treatment response: A post hoc analysis of SUNSHINE and SUNRISE phase 3 trials

被引：0

作者：

Passera, Anna ^{[1
]}

Demanse, David ^{[1
]}

Jemec, Gregor B. E. ^{[2
]}

Okoye, Ginette A. ^{[3
]}

Mayo, Tiffany ^{[4
]}

Hsiao, Jennifer ^{[5
]}

Shi, Vivian Y. ^{[6
]}

Porter, Martina J. ^{[7
,8
]}

Byrd, Angel S. ^{[3
]}

Uhlmann, Lorenz ^{[1
]}

Wei, Xiaoling ^{[9
]}

Vandemeulebroecke, Marc ^{[1
]}

Ravichandran, Shoba ^{[10
]}

Muscianisi, Elisa ^{[10
]}

机构：

[1] Novartis Pharma AG, Basel, Switzerland

[2] Univ Copenhagen, Copenhagen, Denmark

[3] Howard Univ, Coll Med, Washington, DC USA

[4] Univ Alabama Birmingham, Birmingham, AL USA

[5] Univ Southern Calif, Dept Dermatol, Los Angeles, CA USA

[6] Univ Arkansas Med Sci, Little Rock, AR USA

[7] Beth Israel Deaconess Med Ctr, Dept Dermatol, Boston, MA USA

[8] Harvard Med Sch, Dept Dermatol, Boston, MA USA

[9] Novartis Pharmaceut, Shanghai, Peoples R China

[10] Novartis Pharmaceut, E Hanover, NJ USA

来源：

EXPERIMENTAL DERMATOLOGY | 2023年 / 32卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：143 / 144

页数：2

共 50 条

[1] New insights on hidradenitis suppurativa phenotypes and treatment response: An exploratory automated analysis of the SUNSHINE and SUNRISE trials
Passera, Anna
Muscianisi, Elisa
Demanse, David
Okoye, Ginette A.
Jemec, Gregor B. E.
Mayo, Tiffany
Hsiao, Jennifer
Shi, Vivian Y.
Byrd, Angel S.
Wei, Xiaoling
Uhlmann, Lorenz
Vandemeulebroecke, Marc
Ravichandran, Shoba
Porter, Martina L.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024,
[2] Effect of secukinumab on draining tunnels in patients with moderate to severe hidradenitis suppurativa: Post hoc analysis of the SUNSHINE and SUNRISE phase 3 randomized trials
Bechara, Falk G.
Becherel, Pierre-Andre
Reguiai, Ziad
Mendes-Bastos, Pedro
Kirby, Joslyn S.
Hsiao, Jennifer
Bachhuber, Teresa
Wozniak, Magdalena B.
Kasparek, Torben
Ortmann, Christine-Elke
Lobach, Iryna
Field, Clarice
Ravichandran, Shoba
Kimball, Alexa B.
EXPERIMENTAL DERMATOLOGY, 2023, 32 : 140 - 141
[3] Secukinumab in moderate to severe hidradenitis suppurativa: Primary endpoint analysis from the SUNSHINE and SUNRISE Phase 3 trials
Gottlieb, Alice B.
Kimball, Alexa B.
Alavi, Afsaneh
Jemec, Gregor B. E.
Wei, Xiaoling
Wozniak, Magdalena B.
Uhlmann, Lorenz
Martinez, Angela Llobet
Keefe, Deborah
Martin, Ruvie
Chen, Li
Muscianisi, Elisa
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 25 - 26
[4] Comparison of the international hidradenitis suppurativa severity scoring system (IHS4) and hurley staging in hidradenitis suppurativa disease severity assessment: A post hoc analysis of the SUNSHINE and SUNRISE phase 3 trials
Zouboulis, Christos C.
Prens, Errol P.
Sayed, Christopher
Molina-Leyva, Alejandro
Bettoli, Vincenzo
Romanelli, Marco
Szepietowski, Jacek C.
Kasparek, Torben
Lobach, Iryna
Wozniak, Magdalena B.
Ortmann, Christine-Elke
Bachhuber, Teresa
Muscianisi, Elisa
Ravichandran, Shoba
Tzellos, Thrasyvoulos
EXPERIMENTAL DERMATOLOGY, 2023, 32 : 102 - 103
[5] Secukinumab in moderate to severe hidradenitis suppurativa: Analysis of pooled data from the SUNSHINE and SUNRISE phase 3 randomized trials
Alavi, Afsaneh
Reguiai, Ziad
Jemec, Gregor B. E.
Gottlieb, Alice B.
Wozniak, Magdalena B.
Uhlmann, Lorenz
Fan, Heng
Llobet-Martinez, Angela
Ravichandran, Shoba
Kimball, Alexa B.
EXPERIMENTAL DERMATOLOGY, 2023, 32 : 137 - 138
[6] International Hidradenitis Suppurativa Severity Scoring System (IHS4) as a holistic measure of hidradenitis suppurativa disease severity compared with Hurley staging: A post hoc analysis of the SUNRISE and SUNSHINE phase 3 trials of secukinumab
Zouboulis, Christos C.
Prens, Errol P.
Sayed, Christopher J.
Molina-Leyva, Alejandro
Bettoli, Vincenzo
Romanelli, Marco
Szepietowski, Jacek C.
Martinez, Angela Llobet
Kasparek, Torben
Lobach, Iryna
Wozniak, Magdalena B.
Ortmann, Christine-Elke
Thomas, Nicolas
Bachhuber, Teresa
Ravichandran, Shoba
Tzellos, Thrasyvoulos
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (06) : e496 - e499
[7] Efficacy of secukinumab in patients with hidradenitis suppurativa based on the international hidradenitis suppurativa severity scoring system (IHS4): A post hoc analysis of the SUNSHINE and SUNRISE trials
Zouboulis, Christos C.
Kyrgidis, Athanassios
Alavi, Afsaneh
Jemec, Gregor B. E.
Martorell, Antonio
Marzano, Angelo V.
van der Zee, Hessel H.
Muscianisi, Elisa
Kasparek, Torben
Bachhuber, Teresa
Wozniak, Magdalena B.
Ortmann, Christine-Elke
Lobach, Iryna
Ravichandran, Shoba
Tzellos, Thrasyvoulos
EXPERIMENTAL DERMATOLOGY, 2023, 32 : 27 - 28
[8] Secukinumab efficacy in patients with hidradenitis suppurativa assessed by the International Hidradenitis Suppurativa Severity Score System (IHS4): A post hoc analysis of the SUNSHINE and SUNRISE trials
Zouboulis, Christos C.
Kyrgidis, Athanassios
Alavi, Afsaneh
Jemec, Gregor B. E.
Martorell, Antonio
Marzano, Angelo V.
van der Zee, Hessel H.
Wozniak, Magdalena B.
Martinez, Angela Llobet
Kasparek, Torben
Bachhuber, Teresa
Ortmann, Christine-Elke
Lobach, Iryna
Thomas, Nicolas
Ravichandran, Shoba
Tzellos, Thrasyvoulos
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024,
[9] Impact of secukinumab on the need for rescue surgical intervention in patients with moderate to severe hidradenitis suppurativa: Post-hoc analysis of week 16 data from sunshine and sunrise trials
van der Zee, Hessel H.
Szepietowski, Jacek C.
Sayed, Christopher
Guillem, Philippe
Hamzavi, Iltefat H.
Goldberg, Stephanie
Field, Clarice
Ortmann, Christine-Elke
Lobach, Iryna
Wozniak, Magdalena B.
Llobet-Martinez, Angela
Ravichandran, Shoba
Bachhuber, Teresa
Bechara, Falk G.
EXPERIMENTAL DERMATOLOGY, 2023, 32 : 30 - 31
[10] Sustainability of Linaclotide Response in Chronic Idiopathic Constipation Patients: A Post-hoc Pooled Analysis of Two Phase 3 Trials
Lavins, Bernard J.
Fox, Susan M.
Reasner, David
Tripp, Kenneth
Shea, Elizabeth P.
Blakesley, Rick
Shiff, Steven
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S746 - S747

← 1 2 3 4 5 →